CUE Cue Biopharma, Inc. - Common Stock
$20,83
Prix · Mai 20, 2026
Données fondamentales au Mar 16, 2026
Fourchette 52 semaines
$0–$41
50% of range
Note des analystes
BUY
5 analysts
Objectif de cours
$115
+452% upside
P/E (TTM)
-1.1
ROE
-119.3%
Marge nette
-96.9%
CUE Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$20.83
Capitalisation Boursière
$29M
P/E (TTM)
-1.1
BPA (TTM)
$-0.28
Revenus (TTM)
$27M
Rendement div.
—
ROE
-119.3%
Dette/Capitaux propres
—
Fourchette 52 semaines
$0 – $41
CUE Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$27M
2018-12-31
→
2025-12-31
BPA
$-0.28
2021-12-31
→
2025-12-31
Flux de trésorerie libre
$-22M
2020-12-31
→
2025-12-31
Marges
-96.9%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
CUE
Médiane des pairs
P/E (TTM)
-1.1
3.0
P/S (TTM)
1.1
16.8
P/B
1.1
3.5
Price / FCF (Cours / FCF)
-1.3
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
CUE
Médiane des pairs
Operating Margin (Marge d'exploitation)
-96.7%
—
Net Profit Margin (Marge nette)
-96.9%
-665.6%
ROA
-71.5%
-52.0%
ROE
-119.3%
-97.6%
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
CUE
Médiane des pairs
Current Ratio (Ratio de liquidité)
2.7
3.7
Quick Ratio (Ratio de liquidité réduite)
2.4
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
CUE
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
195.8%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
180.5%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
54.2%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
CUE
Médiane des pairs
CUE Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
5 analystes
- Achat fort 1 20,0%
- Achat 3 60,0%
- Conserver 1 20,0%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
1 analystes · 2026-05-14
Bas
$115.00
Haut
$115.00
Objectif médian
$115.00
+452,2%
Objectif moyen
$115.00
+452,2%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.66%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 septembre 2025 | $-2.10 | $-2.83 | 0.73% |
| 30 juin 2025 | $-2.70 | $-4.24 | 1.5% |
| 31 mars 2025 | $-5.10 | $-4.65 | -0.45% |
| 31 décembre 2024 | $-3.90 | $-4.73 | 0.83% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | — |
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | — |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| ANIX | $136M | -12.1 | 0.00% | — | -62.2% | — |
| FBIO | — | — | — | — | — | — |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | — |
| RNTX | — | -0.6 | — | — | — | — |
| CLNN | $64M | — | -41.5% | -13086.5% | 200.2% | — |
| EXOZ | $92M | -10.0 | — | — | -172.3% | — |
| IBIO | $15M | -0.4 | 77.8% | -4594.2% | -101.5% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $27M | $9M | $5M | $1M | $15M | $3M | $3M | $1M | |
| R&D Expense | $38M | $36M | $41M | $39M | $41M | $34M | $27M | $29M | |
| SG&A Expense | $16M | $15M | $17M | $16M | $17M | $15M | $13M | $11M | |
| Operating Expenses | $54M | $51M | $58M | $54M | $59M | $48M | $40M | $40M | |
| Operating Income | $-27M | $-42M | $-52M | $-53M | $-44M | $-45M | $-37M | $-39M | |
| Interest Expense | $100.0K | $100.0K | $100.0K | $109.0K | · | · | · | · | |
| Other Non-op | $450.0K | $826.0K | $1M | $215.0K | $45.9K | $463.9K | $482.8K | $165.3K | |
| Pretax Income | · | · | · | $-53M | $-44M | $-45M | $-36M | $-38M | |
| Income Tax | $500.0K | $0 | · | $0 | $495.0K | $206.2K | $412.5K | $825.0K | |
| Net Income | $-27M | $-41M | $-51M | $-53M | $-44M | $-45M | $-37M | $-39M | |
| EPS (Basic) | $-0.28 | $-0.72 | $-1.11 | $-1.49 | $-1.41 | · | · | · | |
| EPS (Diluted) | $-0.28 | $-0.72 | $-1.11 | $-1.49 | $-1.41 | · | · | · | |
| Shares (Basic) | 94,731,768 | 56,328,348 | 45,754,794 | 35,649,134 | 31,285,418 | · | · | · | |
| Shares (Diluted) | 94,731,768 | 56,328,348 | 45,754,794 | 35,649,134 | 31,285,418 | · | · | · | |
| EBITDA | $-27M | $-42M | $-52M | $-53M | $-44M | $-45M | · | · |
Bilan 23
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $22M | $49M | $52M | $64M | $75M | $44M | $21M | |
| Receivables | $6M | $945.0K | $2M | $57.0K | $3M | $1M | $754.9K | · | |
| Prepaid Expense | $1M | $805.0K | $955.0K | $841.0K | $954.8K | $1M | $860.1K | $1M | |
| Current Assets | $37M | $25M | $51M | $77M | $68M | $88M | $61M | $41M | |
| PP&E (Net) | $241.0K | $471.0K | $795.0K | $1M | $2M | $2M | $2M | $3M | |
| PP&E (Gross) | $4M | $4M | $4M | $6M | $6M | $5M | $4M | $4M | |
| Accum. Depreciation | $4M | $4M | $4M | $4M | $3M | $3M | $2M | $1M | |
| Other Non-current Assets | $94.0K | $105.0K | $117.0K | $128.0K | $140.0K | $401.7K | $673.6K | $808.7K | |
| Total Assets | $42M | $32M | $62M | $91M | $83M | $100M | $72M | $45M | |
| Accounts Payable | $4M | $3M | $4M | $3M | $3M | $2M | $882.7K | $2M | |
| Accrued Liabilities | $2M | $3M | $4M | $4M | $5M | $3M | $2M | $2M | |
| Short-term Debt | · | $37.0K | $37.0K | $74.0K | · | · | · | · | |
| Current Liabilities | $13M | $14M | $17M | $12M | $13M | $16M | $12M | $6M | |
| Capital Leases | $2M | $1M | $3M | $6M | $5M | $2M | $1M | · | |
| Total Liabilities | $16M | $15M | $24M | $26M | $18M | $21M | $17M | $11M | |
| Long-term Debt | · | · | $4M | $8M | · | · | · | · | |
| Total Debt | · | $37.0K | $8M | $10M | · | · | · | · | |
| Common Stock | $97.0K | $62.0K | $47.0K | $43.0K | $32.2K | $30.4K | $26.6K | $20.7K | |
| Retained Earnings | $-368M | $-342M | $-301M | $-250M | $-197M | $-153M | $-109M | $-72M | |
| AOCI | · | $0 | $0 | $-96.0K | $0 | $7.1K | $-10.3K | $-11.0K | |
| Stockholders' Equity | $26M | $17M | $37M | $66M | $65M | $79M | $55M | $34M | |
| Liabilities + Equity | $42M | $32M | $62M | $91M | $83M | $100M | $72M | $45M | |
| Shares Outstanding | 96,621,218 | 61,819,101 | 47,215,116 | 47,215,116 | 32,202,496 | 30,351,366 | 26,562,178 | 20,697,453 |
Flux de trésorerie 13
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $958.0K | $397.0K | $556.0K | $922.0K | $1M | $1M | $810.8K | $760.0K | |
| Stock-based Comp | $5M | $7M | $8M | $9M | $12M | $10M | $7M | $7M | |
| Amort. of Intangibles | · | · | · | · | · | $11.7K | $11.7K | · | |
| Operating Cash Flow | $-22M | $-36M | $-40M | $-42M | $-39M | $-32M | $-31M | $-26M | |
| CapEx | $177.0K | $66.0K | $0 | $171.0K | $913.0K | $595.3K | $46.4K | $2M | |
| Investing Cash Flow | $75.0K | $32.0K | $25M | $-25M | $9M | $4M | $3M | $-20M | |
| Stock Issued | $28M | $11M | $0 | $23M | $0 | $57M | $49M | · | |
| Stock Repurchased | · | · | $0 | $200.0K | $750.1K | $271.1K | $91.0K | · | |
| Net Stock Activity | $28M | $11M | $0 | $23M | $17M | $56M | · | · | |
| Financing Cash Flow | $26M | $10M | $12M | $54M | $19M | $59M | $51M | $4M | |
| Net Change in Cash | $5M | $-26M | $-3M | $-13M | $-10M | $31M | $23M | $-43M | |
| Taxes Paid | $500.0K | $0 | · | · | · | · | · | · | |
| Free Cash Flow | $-22M | $-36M | $-40M | $-42M | $-40M | $-33M | · | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -96.7% | -446.9% | -949.9% | -4274.3% | -292.6% | -1428.0% | · | · | |
| Net Margin | -96.9% | -438.0% | -924.1% | -4257.1% | -295.6% | -1419.8% | · | · | |
| Pretax Margin | · | · | · | -4257.1% | -292.2% | -1413.3% | · | · | |
| EBITDA Margin | -96.7% | -446.9% | -949.9% | -4274.3% | -292.6% | -1428.0% | · | · | |
| ROA | -71.5% | -86.8% | -66.4% | -60.7% | -48.3% | -52.3% | · | · | |
| ROE | -119.3% | -189.8% | -127.2% | -91.0% | -68.5% | -53.8% | · | · | |
| ROIC | · | · | · | -70.2% | -67.5% | -57.3% | · | · |
Liquidité et Solvabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | 1.8 | 3.0 | 6.7 | 5.4 | 5.4 | · | · | |
| Quick Ratio | 2.4 | 1.7 | 2.9 | 4.5 | 5.3 | 4.7 | · | · | |
| Debt / Equity | · | 0.0 | 0.2 | 0.2 | · | · | · | · | |
| LT Debt / Equity | · | 0.0 | 0.1 | 0.1 | · | · | · | · | |
| Interest Coverage | -265.5 | -415.0 | -401.1 | · | · | · | · | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.2 | 0.1 | 0.0 | 0.2 | 0.0 | · | · | |
| Receivables Turnover | 8.5 | 7.0 | 6.3 | 0.8 | 6.6 | 2.9 | · | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 195.8% | 69.2% | 341.0% | -91.7% | 373.7% | · | · | · | |
| Revenue CAGR 3Y | 180.5% | -14.7% | 20.3% | · | · | · | · | · | |
| Revenue CAGR 5Y | 54.2% | · | · | · | · | · | · | · |
Valorisation (TTM) 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $27M | $9M | $5M | $1M | $15M | $3M | $3M | $1M | |
| Net Income TTM | $-27M | $-41M | $-51M | $-53M | $-44M | $-45M | $-37M | $-39M | |
| Market Cap | $29M | $67M | $114M | $123M | $364M | $380M | · | · | |
| Enterprise Value | · | $45M | $73M | $81M | · | · | · | · | |
| P/E | -1.1 | -1.5 | -2.4 | -1.9 | -8.0 | · | · | · | |
| P/S | 1.1 | 7.3 | 20.7 | 98.5 | 24.4 | 120.4 | · | · | |
| P/B | 1.1 | 3.9 | 3.1 | 1.9 | 5.6 | 4.8 | · | · | |
| P / Tangible Book | 1.1 | 3.9 | 3.1 | 1.9 | 5.6 | 4.8 | · | · | |
| P / Cash Flow | -1.4 | -1.9 | -2.8 | -2.9 | -9.4 | -11.7 | · | · | |
| P / FCF | -1.3 | -1.9 | -2.8 | -2.9 | -9.2 | -11.5 | · | · | |
| EV / EBITDA | · | -1.1 | -1.4 | -1.5 | · | · | · | · | |
| EV / FCF | · | -1.2 | -1.8 | -1.9 | · | · | · | · | |
| EV / Revenue | · | 4.8 | 13.4 | 65.2 | · | · | · | · | |
| Earnings Yield | -91.8% | -66.1% | -42.0% | -52.3% | -12.5% | · | · | · |
Compte de résultat 13
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22M | $2M | $3M | $421.0K | $2M | $3M | $3M | $2M | $2M | $2M | $1M | $187.0K | $151.0K | $68.0K | $26.0K | $1M | |
| R&D Expense | $17M | $5M | $8M | $9M | $7M | $9M | $10M | $10M | $11M | $10M | $11M | $9M | $11M | $8M | $10M | $10M | |
| SG&A Expense | $3M | $5M | $4M | $4M | $4M | $3M | $4M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | |
| Operating Expenses | $20M | $10M | $12M | $13M | $11M | $12M | $13M | $14M | $16M | $14M | $15M | $14M | $15M | $11M | $13M | $15M | |
| Operating Income | $2M | $-8M | $-9M | $-12M | $-10M | $-9M | $-10M | $-13M | $-14M | $-11M | $-14M | $-13M | $-15M | $-11M | $-13M | $-14M | |
| Interest Expense | · | · | · | · | · | · | · | $33.0K | $-537.0K | $254.0K | $350.0K | $33.0K | $18.0K | $33.0K | $33.0K | $25.0K | |
| Other Non-op | $108.0K | $147.0K | $153.0K | $42.0K | $138.0K | $155.0K | $212.0K | $321.0K | $399.0K | $414.0K | $332.0K | $271.0K | $274.0K | $76.0K | $-118.0K | $-17.0K | |
| Net Income | $2M | $-7M | $-8M | $-12M | $-9M | $-9M | $-10M | $-12M | $-13M | $-11M | $-13M | $-13M | $-15M | $-11M | $-13M | $-14M | |
| EPS (Basic) | $0.05 | $-0.07 | $-0.09 | $-0.17 | $-0.10 | $-0.17 | $-0.20 | $-0.25 | $-0.29 | $-0.24 | $-0.29 | $-0.29 | $-0.37 | $-0.31 | $-0.37 | $-0.44 | |
| EPS (Diluted) | $0.05 | $-0.07 | $-0.09 | $-0.17 | $-0.10 | $-0.17 | $-0.20 | $-0.25 | $-0.29 | $-0.24 | $-0.29 | $-0.29 | $-0.37 | $-0.31 | $-0.37 | $-0.44 | |
| Shares (Basic) | -175,851,682 | 100,869,349 | 95,459,401 | 74,254,700 | -94,542,820 | 51,229,701 | 50,174,756 | 49,466,711 | -90,054,874 | 46,358,555 | 44,798,760 | 44,652,353 | -67,728,022 | 35,383,430 | 35,357,343 | 32,636,383 | |
| Shares (Diluted) | -175,851,682 | 100,869,349 | 95,459,401 | 74,254,700 | -94,542,820 | 51,229,701 | 50,174,756 | 49,466,711 | -90,054,874 | 46,358,555 | 44,798,760 | 44,652,353 | -67,728,022 | 35,383,430 | 35,357,343 | 32,636,383 | |
| EBITDA | · | $-8M | $-9M | $-12M | · | $-9M | $-10M | $-13M | · | $-11M | $-14M | $-13M | · | $-11M | $-13M | $-14M |
Bilan 23
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $12M | $27M | $13M | $22M | $32M | $30M | $41M | $49M | $55M | $53M | $56M | $52M | $30M | $66M | $68M | |
| Receivables | $6M | $387.0K | $532.0K | $0 | $945.0K | $3M | $2M | $1M | $2M | $2M | $1M | $196.0K | $57.0K | $796.0K | $736.0K | $925.0K | |
| Prepaid Expense | $1M | $3M | $2M | $2M | $805.0K | $2M | $2M | $2M | $955.0K | $1M | $2M | $2M | $841.0K | $2M | $2M | $2M | |
| Current Assets | $37M | $26M | $31M | $16M | $25M | $37M | $34M | $45M | $51M | $58M | $61M | $69M | $77M | $62M | $69M | $76M | |
| PP&E (Net) | $241.0K | $307.0K | $454.0K | $523.0K | $471.0K | $570.0K | $667.0K | $754.0K | $795.0K | $1M | $1M | $1M | $1M | $2M | $2M | $2M | |
| PP&E (Gross) | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Accum. Depreciation | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-current Assets | $94.0K | $96.0K | $283.0K | $102.0K | $105.0K | $108.0K | $111.0K | $114.0K | $117.0K | $120.0K | $123.0K | $125.0K | $128.0K | $131.0K | $134.0K | $137.0K | |
| Total Assets | $42M | $32M | $41M | $22M | $32M | $45M | $42M | $54M | $62M | $69M | $73M | $82M | $91M | $76M | $85M | $91M | |
| Accounts Payable | $4M | $2M | $4M | $4M | $3M | $6M | $4M | $4M | $4M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | |
| Accrued Liabilities | $2M | $2M | $2M | $4M | $3M | $3M | $5M | $5M | $4M | $5M | $4M | $3M | $4M | $4M | $4M | $3M | |
| Short-term Debt | · | · | · | $100.0K | · | · | · | $37.0K | · | · | · | · | · | $37.0K | · | · | |
| Current Liabilities | $13M | $16M | $19M | $15M | $14M | $17M | $16M | $18M | $17M | $17M | $16M | $14M | $12M | $10M | $8M | $11M | |
| Capital Leases | $2M | $3M | $3M | $176.0K | $1M | $1M | $2M | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $7M | $5M | |
| Total Liabilities | $16M | $18M | $23M | $16M | $15M | $19M | $21M | $24M | $24M | $26M | $27M | $27M | $26M | $26M | $25M | $26M | |
| Long-term Debt | · | · | · | · | · | $1M | $2M | $3M | · | $5M | $6M | $7M | · | $9M | $10M | $10M | |
| Total Debt | · | · | · | $100.0K | · | $5M | $6M | $7M | · | $9M | $10M | $10M | · | $10M | $10M | $10M | |
| Common Stock | $97.0K | $78.0K | $76.0K | $62.0K | $62.0K | $60.0K | $48.0K | $48.0K | $47.0K | $45.0K | $44.0K | $43.0K | $43.0K | $35.0K | $35.0K | $34.0K | |
| Retained Earnings | $-368M | $-370M | $-363M | $-354M | $-342M | $-332M | $-324M | $-314M | $-301M | $-288M | $-277M | $-264M | $-250M | $-236M | $-225M | $-212M | |
| AOCI | · | $1.0K | · | · | · | · | · | · | · | $0 | $-5.0K | $-39.0K | $-96.0K | $-92.0K | · | $0 | |
| Stockholders' Equity | $26M | $13M | $18M | $7M | $17M | $25M | $22M | $30M | $37M | $43M | $46M | $55M | $66M | $51M | $60M | $65M | |
| Liabilities + Equity | $42M | $32M | $41M | $22M | $32M | $45M | $42M | $54M | $62M | $69M | $73M | $82M | $91M | $76M | $85M | $91M | |
| Shares Outstanding | 96,621,218 | 77,781,743 | 76,446,884 | 61,819,101 | 61,819,101 | 60,207,717 | 48,643,316 | 48,643,316 | 47,215,116 | 45,123,281 | 43,744,414 | 43,178,150 | 47,215,116 | 35,385,582 | 35,381,743 | 34,174,800 |
Flux de trésorerie 11
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $678.0K | $80.0K | $99.0K | $101.0K | $98.0K | $101.0K | $99.0K | $99.0K | $113.0K | $130.0K | $136.0K | $177.0K | $203.0K | $201.0K | $215.0K | $303.0K | |
| Stock-based Comp | $610.0K | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Operating Cash Flow | $-1M | $-9M | $-3M | $-8M | $-9M | $-8M | $-10M | $-10M | $-11M | $-8M | $-10M | $-11M | $-11M | $-7M | $-13M | $-12M | |
| CapEx | $0 | $0 | $27.0K | $150.0K | $2.0K | $-1.0K | $10.0K | $55.0K | $0 | $0 | $0 | $0 | $1.0K | $78.0K | $65.0K | $27.0K | |
| Investing Cash Flow | $7M | $-7M | $-27.0K | $-150.0K | $-1.0K | $98.0K | $-10.0K | $-55.0K | $0 | $5M | $5M | $15M | $5M | $-30M | $-62.0K | $-27.0K | |
| Stock Issued | $10M | $0 | · | · | $-8.0K | $11M | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $9.0K | $0 | $191.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-191.0K | |
| Financing Cash Flow | $9M | $1.0K | $18M | $-1M | $-932.0K | $10M | $-1M | $2M | $5M | $5M | $2M | $388.0K | $27M | $-9.0K | $11M | $15M | |
| Net Change in Cash | $15M | $-16M | $14M | $-9M | $-10M | $2M | $-11M | $-7M | $-6M | $2M | $-3M | $5M | $22M | $-36M | $-2M | $4M | |
| Free Cash Flow | · | · | · | $-8M | · | · | · | $-10M | · | · | · | $-11M | · | · | · | $-12M |
Rentabilité 5
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -353.4% | -292.3% | -2921.4% | · | -264.2% | -390.6% | -737.8% | · | -543.8% | -978.1% | -7155.1% | · | -16222.1% | -50346.2% | -1423.8% | |
| Net Margin | · | -346.6% | -287.1% | -2911.4% | · | -259.6% | -382.7% | -719.1% | · | -524.0% | -954.0% | -7010.2% | · | -16110.3% | -50800.0% | -1425.5% | |
| EBITDA Margin | · | -353.4% | -292.3% | -2921.4% | · | -264.2% | -390.6% | -737.8% | · | -543.8% | -978.1% | -7155.1% | · | -16222.1% | -50346.2% | -1423.8% | |
| ROA | · | -19.5% | -20.4% | -32.2% | · | -15.2% | -17.6% | -18.2% | · | -15.2% | -16.7% | -15.2% | · | -14.1% | -15.1% | -15.9% | |
| ROE | · | -38.6% | -42.6% | -67.0% | · | -25.5% | -30.1% | -29.0% | · | -23.6% | -24.9% | -21.9% | · | -19.2% | -19.9% | -21.2% |
Liquidité et Solvabilité 5
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.7 | 1.6 | 1.0 | · | 2.2 | 2.1 | 2.5 | · | 3.3 | 3.7 | 5.0 | · | 6.0 | 8.3 | 6.7 | |
| Quick Ratio | · | 0.8 | 1.5 | 0.8 | · | 2.1 | 1.9 | 2.3 | · | 3.3 | 3.3 | 4.1 | · | 3.0 | 8.0 | 6.0 | |
| Debt / Equity | · | · | · | 0.0 | · | 0.2 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | |
| LT Debt / Equity | · | · | · | · | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | -383.9 | · | -45.0 | -38.6 | -40.5 | · | -89.0 | -63.5 | -569.5 |
Efficacité 2
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | 0.1 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | 1.2 | 2.5 | 0.6 | · | 1.4 | 1.8 | 2.2 | · | 1.7 | 1.5 | 0.3 | · | 0.1 | 0.0 | 0.9 |
Valorisation (TTM) 14
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $9M | $9M | $8M | · | $10M | $8M | $5M | · | $4M | $2M | $1M | · | $3M | $6M | $8M | |
| Net Income TTM | · | $-37M | $-40M | $-43M | · | $-42M | $-47M | $-50M | · | $-48M | $-50M | $-52M | · | $-51M | $-51M | $-50M | |
| Market Cap | · | $56M | $52M | $56M | · | $46M | $60M | $92M | · | $104M | $160M | $154M | · | $79M | $88M | $167M | |
| Enterprise Value | · | · | · | $43M | · | $18M | $37M | $58M | · | $58M | $117M | $108M | · | $59M | $32M | $109M | |
| P/E | · | -1.4 | -1.1 | -1.2 | · | -0.9 | -1.3 | -1.8 | · | -2.0 | -2.9 | -2.5 | · | -1.5 | · | · | |
| P/S | · | 6.3 | 5.6 | 6.9 | · | 4.6 | 7.7 | 17.1 | · | 27.8 | 96.0 | 120.3 | · | 22.6 | 14.3 | 21.7 | |
| P/B | · | 4.2 | 2.9 | 8.6 | · | 1.8 | 2.8 | 3.1 | · | 2.4 | 3.5 | 2.8 | · | 1.6 | 1.5 | 2.6 | |
| P / Tangible Book | · | 4.2 | 2.9 | 8.6 | · | 1.8 | 2.8 | 3.1 | · | 2.4 | 3.5 | 2.8 | · | 1.6 | 1.5 | 2.6 | |
| P / Cash Flow | · | · | · | -6.9 | · | · | · | -9.4 | · | · | · | -14.2 | · | · | · | -14.4 | |
| P / FCF | · | · | · | -6.8 | · | · | · | -9.3 | · | · | · | -14.2 | · | · | · | -14.4 | |
| EV / EBITDA | · | · | · | -3.5 | · | -2.1 | -3.5 | -4.6 | · | -5.1 | -8.6 | -8.1 | · | -5.4 | -2.4 | -7.6 | |
| EV / FCF | · | · | · | -5.2 | · | · | · | -5.9 | · | · | · | -10.0 | · | · | · | -9.4 | |
| EV / Revenue | · | · | · | 5.3 | · | 1.9 | 4.7 | 10.8 | · | 15.6 | 70.3 | 84.2 | · | 17.0 | 5.2 | 14.1 | |
| Earnings Yield | · | -69.5% | -92.4% | -86.7% | · | -113.6% | -79.0% | -56.6% | · | -49.1% | -34.5% | -39.5% | · | -68.6% | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $27M | $9M | $5M | $1M | $15M |
| Marge d'exploitation % | -96.7% | -446.9% | -949.9% | -4274.3% | -292.6% |
| Résultat net | $-27M | $-41M | $-51M | $-53M | $-44M |
| BPA dilué | $-0.28 | $-0.72 | $-1.11 | $-1.49 | $-1.41 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | — | 0.0 | 0.2 | 0.2 | — |
| Ratio de liquidité | 2.7 | 1.8 | 3.0 | 6.7 | 5.4 |
| Ratio de liquidité réduite | 2.4 | 1.7 | 2.9 | 4.5 | 5.3 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-22M | $-36M | $-40M | $-42M | $-40M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.